These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry. Becher PM; Savarese G; Benson L; Dahlström U; Karlström P; Mol PGM; Metra M; Bhatt DL; Pitt B; Lund LH Eur Heart J Cardiovasc Pharmacother; 2023 Jun; 9(4):343-352. PubMed ID: 36718512 [TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Kristensen SL; Jhund PS; Køber L; Preiss D; Kjekshus J; McKelvie RS; Zile MR; Anand IS; Wikstrand J; Wedel H; Komajda M; Carson PE; Cleland JG; McMurray JJ Eur J Heart Fail; 2015 Feb; 17(2):169-76. PubMed ID: 25756844 [TBL] [Abstract][Full Text] [Related]
13. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. Kelly JP; Cooper LB; Gallup D; Anstrom KJ; Chen HH; Redfield MM; O'Connor CM; Mentz RJ; Hernanadez AF; Felker GM Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514750 [TBL] [Abstract][Full Text] [Related]
14. Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction. Parikh RV; Go AS; Bhatt AS; Tan TC; Allen AR; Feng KY; Hamilton SA; Tai AS; Fitzpatrick JK; Lee KK; Adatya S; Avula HR; Sax DR; Shen X; Cristino J; Sandhu AT; Heidenreich PA; Ambrosy AP J Am Heart Assoc; 2023 Oct; 12(19):e029736. PubMed ID: 37776209 [TBL] [Abstract][Full Text] [Related]
15. Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System. Leung CJ; Bhatt AS; Go AS; Parikh RV; Garcia EA; LE KC; Low D; Allen AR; Fitzpatrick JK; Adatya S; Sax DR; Goyal P; Varshney AS; Sandhu AT; Gustafson SE; Ambrosy AP J Card Fail; 2024 Aug; 30(8):981-990. PubMed ID: 38697466 [TBL] [Abstract][Full Text] [Related]
16. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. O'Connor CM; Stough WG; Gallup DS; Hasselblad V; Gheorghiade M J Card Fail; 2005 Apr; 11(3):200-5. PubMed ID: 15812748 [TBL] [Abstract][Full Text] [Related]
17. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial. Krim SR; Anand S; Greene SJ; Chen A; Wojdyla D; Vilaro J; Haught H; Herre JM; Eisenstein EL; Anstrom KJ; Pitt B; Velazquez EJ; Mentz RJ JAMA Cardiol; 2024 Feb; 9(2):182-188. PubMed ID: 37955908 [TBL] [Abstract][Full Text] [Related]
18. Real-Life Data on Readmissions of Worsening Heart Failure Outpatients in a Heart Failure Clinic. Inácio H; De Carvalho A; Gamelas De Carvalho J; Maia A; Durão-Carvalho G; Duarte J; Rodrigues C; Araújo I; Henriques C; Fonseca C Cureus; 2023 Feb; 15(2):e35611. PubMed ID: 37007323 [TBL] [Abstract][Full Text] [Related]
19. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR; JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761 [TBL] [Abstract][Full Text] [Related]
20. Outpatient Worsening Heart Failure as a Target for Therapy: A Review. Greene SJ; Mentz RJ; Felker GM JAMA Cardiol; 2018 Mar; 3(3):252-259. PubMed ID: 29387880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]